Joint Formulary & PAD

Tiotropium bromide (Spiriva Respimat) - Chronic Obstructive Pulmonary Disease (COPD)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Soft mist inhaler
Associated Icons :
Restrictions / Comments :

PAD Profile

ChemicalSubstance :
Tiotropium bromide (Spiriva Respimat)
Indication :
Chronic Obstructive Pulmonary Disease (COPD)
Group Name :
LAMA
Keywords :
LAMAs, antimuscarinic bronchodilators, respiratory, long-acting muscarinic antagonist
Brand Names Include :
Spiriva Respimat
Important Information :

Combination with LABA recommended in COPD.

Prescribe by BRAND.

Latest Additions Date From :
Latest Additions Date To :
Supporting Documents :
4

Other Indications

Below are listed other indications that Tiotropium bromide (Spiriva Respimat) is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Chronic Obstructive Pulmonary Disease (COPD).

Committee Recommendations (1)

The locally preferred LAMA devices are as follows:

  • Spiriva Respimat (tiotropium soft mist inhaler). Re-usable device.
  • Incruse Ellipta (Umeclidinium DPI)
  • Seebri Breezhaler (Glycopyrronium DPI)
  • Eklira Genuair (Aclidinium DPI)

Devices should be prescribed by BRAND

See full COPD guidelines for more information